Cargando…
Forecasting drug utilization and expenditure: ten years of experience in Stockholm
BACKGROUND: Operating under constrained budgets, payers and providers globally face challenges in enabling appropriate and sustainable access to new medicines. Among payer initiatives aiming to improve preparedness of healthcare systems for the introduction of new medicines, drug utilization and exp...
Autores principales: | Linnér, Love, Eriksson, Irene, Persson, Marie, Wettermark, Björn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212573/ https://www.ncbi.nlm.nih.gov/pubmed/32393238 http://dx.doi.org/10.1186/s12913-020-05170-0 |
Ejemplares similares
-
Forecasting drug utilization and expenditure in a metropolitan health region
por: Wettermark, Björn, et al.
Publicado: (2010) -
Valproic acid utilization among girls and women in Stockholm: Impact of regulatory restrictions
por: Karlsson Lind, Linnéa, et al.
Publicado: (2018) -
The Stockholm CREAtinine Measurements (SCREAM) project: protocol overview and regional representativeness
por: Runesson, Björn, et al.
Publicado: (2016) -
Factors associated with antithrombotic treatment decisions for stroke prevention in atrial fibrillation in the Stockholm region after the introduction of NOACs
por: Komen, Joris, et al.
Publicado: (2017) -
EU pharmaceutical expenditure forecast
por: Urbinati, Duccio, et al.
Publicado: (2014)